Bifogade filer
Kurs
+12,05%
Likviditet
0,20 MSEK
Kalender
Tid* | ||
2025-03-13 | 13:30 | Kvartalsrapport 2025-Q3 |
2025-01-08 | - | Extra Bolagsstämma 2025 |
2024-11-28 | - | Kvartalsrapport 2025-Q2 |
2024-10-12 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2024-09-16 | - | Kvartalsrapport 2025-Q1 |
2024-06-26 | - | Bokslutskommuniké 2024 |
2024-03-27 | - | Kvartalsrapport 2024-Q3 |
2023-12-21 | - | Kvartalsrapport 2024-Q2 |
2023-11-15 | - | Extra Bolagsstämma 2024 |
2023-10-27 | - | Årsstämma |
2023-10-13 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2023-09-20 | - | Kvartalsrapport 2024-Q1 |
2023-06-23 | - | Bokslutskommuniké 2023 |
2023-05-09 | - | Extra Bolagsstämma 2023 |
2023-03-28 | - | Kvartalsrapport 2023-Q3 |
2022-12-21 | - | Kvartalsrapport 2023-Q2 |
2022-10-31 | - | Årsstämma |
2022-10-14 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2022-09-29 | - | Kvartalsrapport 2023-Q1 |
2022-06-29 | - | Bokslutskommuniké 2022 |
2022-03-21 | - | Kvartalsrapport 2022-Q3 |
2022-03-15 | - | Extra Bolagsstämma 2022 |
2021-12-29 | - | Kvartalsrapport 2022-Q2 |
2021-10-20 | - | Extra Bolagsstämma 2021 |
2021-10-11 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2021-09-29 | - | Kvartalsrapport 2022-Q1 |
2021-06-24 | - | Bokslutskommuniké 2021 |
2021-03-16 | - | Kvartalsrapport 2021-Q3 |
2020-12-14 | - | Kvartalsrapport 2021-Q2 |
2020-10-20 | - | Årsstämma |
2020-10-15 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2020-09-28 | - | Kvartalsrapport 2021-Q1 |
2020-06-25 | - | Bokslutskommuniké 2020 |
2020-03-12 | - | Kvartalsrapport 2020-Q3 |
2019-12-17 | - | Kvartalsrapport 2020-Q2 |
2019-10-16 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2019-10-15 | - | Årsstämma |
2018-09-27 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2018-09-26 | - | Årsstämma |
2018-06-18 | - | Extra Bolagsstämma 2019 |
2018-06-12 | - | Bokslutskommuniké 2018 |
2018-03-12 | - | Kvartalsrapport 2018-Q3 |
2017-09-26 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2017-09-25 | - | Årsstämma |
2017-09-11 | - | Kvartalsrapport 2018-Q1 |
2017-06-19 | - | Bokslutskommuniké 2017 |
2017-03-13 | - | Kvartalsrapport 2017-Q3 |
2017-01-01 | - | Extra Bolagsstämma 2018 |
2016-11-30 | - | Kvartalsrapport 2017-Q2 |
2016-09-06 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2016-09-05 | - | Årsstämma |
2016-09-05 | - | Kvartalsrapport 2017-Q1 |
2016-06-13 | - | Bokslutskommuniké 2016 |
2016-02-22 | - | Kvartalsrapport 2016-Q3 |
2016-02-16 | - | Extra Bolagsstämma 2017 |
2015-11-30 | - | Kvartalsrapport 2016-Q2 |
2015-09-08 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2015-09-07 | - | Årsstämma |
2015-09-07 | - | Kvartalsrapport 2016-Q1 |
2015-06-16 | - | Bokslutskommuniké 2015 |
2015-03-16 | - | Kvartalsrapport 2015-Q3 |
2014-12-01 | - | Kvartalsrapport 2015-Q2 |
2014-10-07 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2014-10-06 | - | Årsstämma |
2014-10-06 | - | Kvartalsrapport 2015-Q1 |
2014-06-30 | - | Bokslutskommuniké 2014 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
Phase Holographic Imaging PHI AB ("PHI" or the "Company") hereby announces that the Company's largest shareholder Altium SA ("Altium") and PHI has agreed on an underwriting commitment (so-called "top-down" or "top guarantee") free-of-charge in the ongoing exercise of warrants of series TO 3 ("TO 3"). The underwriting commitment covers approx. SEK 1.5 million, corresponding to approx. 12 percent of the issue proceeds that the Company can receive through the exercise of TO 3. Altium has, as previously communicated, also exercised its TO 3 to subscribe for new shares in PHI.
In the ongoing exercise of TO 3, PHI has agreed on an underwriting commitment with Altium. The underwriting commitment covers approx. SEK 1.5 million, corresponding to approx. 12 percent of the issue proceeds that the Company can receive through the exercise of TO 3.
The underwriting commitment is a so-called "top-down guarantee" or "top guarantee", which means that if TO 3 is exercised to 88 percent, underwriting subscription is executed for the remaining 10 percent up to a fully subscribed TO 3. The underwriting commitment is thus added to the current subscription level for TO 3 and aims to ensure the last part of the subscription in the warrant exercise in case all TO 3 are not exercised by existing holders. No compensation is paid for the underwriting commitment. The underwriting commitment has not been secured through advance transaction, bank guarantee or similar.
If underwriting commitment is activated, subscription of shares will take place through a directed share issue which will be carried out after the exercise period for TO 3 has ended. Subscription in such directed new share issue will take place to the established price for TO 3 and only to the extent that TO 3 has not been exercised by existing holders within the context of the size of the underwriting commitments (equivalent to a maximum of 400,000 shares in the Company). The Board of Directors will not decide on the directed share issue to use the underwriting commitment in case the Board of Directors does not consider it justifiable taking into account a customary issue cost.
Advisors
In connection with the exercise of warrants of series TO 3, Sedermera Corporate Finance AB is acting as financial advisor, Markets & Corporate Law Nordic AB as legal advisor and Nordic Issuing AB as issuing agent. Shark Communication AB is assisting the Company with advice regarding communication.
For more information about the warrants of series TO 3, please contact:
Sedermera Corporate Finance AB
Phone: +46 (0) 40 615 14 10
E-mail: cf@sedermera.se
www.sedermera.se
This disclosure contains information that Phase Holographic is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 21-04-2023 08:04 CET.
Patrik Eschricht
E-mail: ir@phiab.com (ir@phiab.se)
Web: www.phiab.com - Live cell imaging & analysis